SOURCE LOGIN
|
中文版
Email:
Password:
Forget your password?
David Pieroni, Managing Director of Automation Quality Solutions (AQS)
More podcasts
There will be blood... Shenzhen Guangming plans new plasma product facility
Monday, February 8, 2010
Shenzhen Weiwu Guangming Biological Products announced February 3 that it will invest RMB 170 million to build the largest blood-products production base in southern China, according to www.qq.com.
Guangming Biological Products will establish a new 16,000 square-meter blood-products line within the pre-existing factory location. After the completion of the project, the annual handling capacity of blood plasma will reach 300 tons with a production value of nearly RMB 300 million.
Shenzhen WeiWu Guangming Biological Products has specialized in the development and production of biological products for 20 years, and is one of the largest blood product companies in Guangdong Province. According to GBI SOURCE, the company currently has nine products registered in China including albumin and human immunoglobulins.
